Research Advances and Clinical Impact of New Data From Crohn’s and Colitis Congress^® 2021*

At the 2021 virtual congress, I was excited by select studies on emerging therapeutic approaches that remind us there is more to treating IBD than suppressing the immune system.

Bruce E. Sands, MD, MS Released: March 1, 2021

In this commentary, I present my take on interesting new data from the 2021 virtual Crohn’s & Colitis Congress on the relationship between visceral adipose tissue and outcomes for patients with IBD and the role of diet in IBD management.

Anita Afzali, MD, MPH, MHCM, FACG, AGAF Released: March 5, 2021